Coverage
Filings
| Filing | Date |
|---|---|
| Major Shareholder Announcement | 18 Jan 2010 |
| Articles of Association of Genmab A/S | 6 Jan 2010 |
| Genmab's Financial Calendar for 2010 | 21 Dec 2009 |
| Grant of Warrants to Employees in Genmab A/S | 9 Dec 2009 |
| Genmab Announces RG1507 Update | 4 Dec 2009 |
| Genmab to present at 21st Annual Piper Jaffray Health Care Conference | 25 Nov 2009 |
| Major Shareholder Announcement | 24 Nov 2009 |
| Interim Report for the 9 months ended September 30, 2009 |
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 10 Nov 2009 |
| Genmab Announces Results for the Nine Months Period of 2009 | 10 Nov 2009 |
| Genmab to Present Data from Multiple Studies at ASH | 10 Nov 2009 |
| Genmab Announces Start of Ofatumumab Phase III Head to Head Study in DLBCL | 9 Nov 2009 |
| Genmab Reorganizes to Build Sustainable Business | 5 Nov 2009 |